BioMed Research International / 2019 / Article / Tab 1

Research Article

Prevalence of Metabolic Syndrome and Its Components in Bamboutos Division’s Adults, West Region of Cameroon

Table 1

Features of persons who participated in the study according to sex in total participants.

Total participantsMalesFemalesp value (between male and female)
Total, n (%)604257 (57.45)347 (42.55)

Age (years43.74±17.2140.87±17.2945.87±16.87< 0.001

Educational level, n (%Uneducated11 (1.82)1 (2.88)10 (0.39)< 0.001
Primary200 (33.11)66 (38.62)134 (25.68)
secondary305 (50.50)136 (48.70)169 (52.92)
University88 (14.57)54 (9.80)34 (21.01)

Residence area, n (%0.487
Mbouda424 (70.20)188 (73.15)236 (68.01)
Batcham118 (19.54)45 (17.51)73 (21.04)
Galim35 (5.79)15 (5.84)20 (5.76)
Babadjou27 (4.47)9 (3.50)18 (5.19)

Drinking, n (%< 0.001
Never drinker119 (19.70)40 (15.56)79 (22.77)
Moderate alcohol drinker299 (49.50)117 (45.53)182 (52.45)
Excessive alcohol drinker186 (30.79)100 (38.91)86 (24.78)

Smoking, n (%< 0.001
Current smoker21 (3.48)20 (7.78)1 (0.29)
Former smoker69 (11.42)47 (18.29)22 (6.34)
Never smoker514 (85.10)190 (73.93)324 (93.37)

BMI (kg/m2;27.45±6.1626.69±5.2228.02±6.720.006

BMI, n (%0.004
Underweight16 (2.65)4 (1.56)12 (3.46)
Normal weight222 (36.75)105 (40.86)117 (33.72)
Overweight176 (29.14)85 (33.07)91 (26.22)
Obesity190 (31.46)63 (24.51)127 (36.60)

Physical activity, n (%)0.001
Low405 (67.05)154 (59.92)251 (72.33)
Moderate147 (24.34)70 (27.24)77 (22.19)
High41 (6.79)28 (10.89)13 (3.75)
Very high11 (1.82)5 (1.95)6 (1.73)

Waist circumference (cm;83.68±16.6485.27±15.1582.51±17.590.039

Abdominal obesity, n (%< 0.001
No360 (59.60)202 (78.60)158 (45.53)
Yes244 (40.40)55 (21.40)189 (54.47)

Diabetes, n (%37 (6.13)16 (6.23)21 (6.05)0.929

Hypertension, n (%266 (44.04)119 (46.30)147 (42.36)0.334

Hyper-LDL cholesterol, n (%138 (22.85)49 (19.07)89 (25.65)0.056

Hyper-total cholesterol, n (%163 (26.99)62 (24.12)101 (29.11)0.172

Hypo-total cholesterol, n (%291 (48.18)137 (53.31)154 (44.38)0.029

Hypertriglyceridemia, n (%326 (53.97)149 (57.98)177 (51.01)0.089

Hypo-HDL cholesterol, n (%500 (82.78)200 (77.82)300 (86.46)0.005

Diastolic blood pressure (mmHg; [min-max]80.39±12.55 40-12080.95±10.87 54-11279.97±13.67 40-1200.329

Systolic blood pressure (mmHg; [min-max]129.20±20.89 80-195131.49±21.11 100-195127.50±20.58 80-1880.020

Glycaemia (mg/dl; [min-max]98.90±34.68 54-44897.61±27.70 55-18399.85±39.07 54-4480.411

HDL cholesterol (mg/dl; [min-max]33.10±15.27 3-19032.64±13.55 3-12633.44±16.44 8-1900.513

LDL cholesterol (mg/dl; [min-max]95.14±74.67 10-35790.58±68.82 30-35798.52±78.67 10-2610.187

Total cholesterol (mg/dl; [min-max]159.88±76.23 37-618155.34±68.33 38-417163.24±81.53 37-6180.196

Triglyceride (mg/dl; [min-max]168.48±71.81 24-479169.82±70.99 24-479167.48±72.49 30-4300.691

hs-CRP (mg/l)5.88±16.58 0.005-1923.94±12.28 0.005-967.32±19.05 0.005-1920.008

, BMI, diastolic blood pressure; systolic blood pressure; glycaemia; HDL cholesterol; LDL cholesterol; total cholesterol; and triglyceride were expressed as mean ± SD. BMI, body mass index.
t-test; -square.
MetS, metabolic syndrome; HDL, high-density lipoprotein; LDL, low-density lipoprotein; n, size; min, minimum; max, maximum.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.